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We worked on finding a new kinase regulator to develop basic data to be used for 
cancer prevention.  Our work found a link between three previously unrelated proteins 
involved in cancer, ERK2 and ERK6 and Scribble. The MAP kinase cascade is involved 
in cell proliferation, which is highly deregulated in cancer.   Through the screening of 
ERK6 associating molecules, we found the cell polarity, and cell cycle related molecule 
Scribble. Furthermore, we found that Scribble was a dual-specific kinase regulator. We 
clearly demonstrated that these ERKs interact with Scribble through the LRR and the 
PDZ domains of Scribble.  We hypothesize that Scribble may function as a scaffolding 
protein for ERK2 and ERK6, since Scribble has been found to down regulate the kinase 
activity of these ERKs.    
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Introduction and Background 
 
1.1 Cancer 
In 2008, the American Cancer Society predicts 1,437,180 new cases of cancer 
will be diagnosed.  The causes of cancer can be from an external or internal source, or a 
combination of them both.  External sources include chemicals, tobacco, radiation and 
infections.  Internal sources include mutations that are inherited or caused by metabolism, 
hormones or can result from immune disorders (American Cancer Society). The cancer 
phenotype includes the loss of controlled cell proliferation, tissue invasion, and often 
culminates in metastasis.  Normal cell growth is tightly regulated and has several 
characteristic biological phenotypes, such as contact inhibition, limited proliferative 
capacity, and a dependency on the interactions between growth factors and the extra 
cellular matrix (ECM).  In general, cancer is the result of multiple genetic modifications 
which allow the cell to escape the growth restrictions of normal cells.  For example, 
contact inhibition, which prevents normal cells from growing over adjacent cells, must be 
overcome.  Moreover, the number of cellular divisions before a cell enters senescence 
phase must increase significantly.  Interaction dependency, which requires signals from 
integrins and the ECM for continued cell growth must no longer be necessary.  Any 
possible combinations of these mutations may lead to the development of the 
uncontrolled growth of the cancer cell. 
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  Uncontrolled cell proliferation rates are commonly the result of genetic damage.  
Generally, primary genetic damage causes the accumulation of consecutive mutations in 
proto-oncogenes and tumor-suppressor genes.  Proto-oncogenes are responsible for 
regulating proliferation in the cell. Frequently, mutations in Proto-oncogenes cause the 
proteins to become constitutively active.   Tumor-suppressor genes oppose the active 
function of proto-oncogenes, by promoting anti-proliferative regulatory mechanisms. A 
mutation in a tumor-suppressor gene can cause a loss of its function, and it may result in 
the loss of the anti-proliferative phenotype.  At least two hits resulting in genetic 
mutations are needed to cause the cell to develop a malignant phenotype.  Generally, the 
first is “the gain of function mutation” in an oncogene, and the second is “a loss of 
function mutation” in a tumor-suppressor gene (Lodish, 2008)  
 
1.2 MAP Kinases 
The canonical MAP kinase pathway has been studied for decades as a possible 
therapeutic target for cancer treatment.  MAP Kinase signaling promotes cellular 
activities, such as cell proliferation, differentiation, survival and metastasis.  In cancer, 
this pathway is frequently aberrantly activated, particularly by the pathway activating 
epidermal growth factor receptor (EGFR), and the intracellular transducer Ras small 
guanosine triphosphatases (GTPases) families (Sebolt-Leopold and Herrera, 2004).   
Mammalian cells contain four major MAP Kinase cascades.  Each cascade 
possesses three protein kinases, each of which have a common name describing their 
location in the sequence of signal transduction. MAPK kinase kinase (MAPKKK) is 
activated by Ras, then MAPKKK activates MAPK kinase (MAPKK), followed by 
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MAPKK activating MAPK (Johnson and Lapadat, 2002).  Each kinase serves as a 
connector between the upstream activators, and the downstream substrate, through the 
transfer of a phosphate.  The terminal kinase, or MAPK, is often used to name the protein 
cascade.  Hence, the pathways are referred to as ERK1 and 2, p38 (p38α, p38β, p38γ 
(ERK6)), c-Jun N-terminal kinases, and ERK5.  All four pathways are activated by 
growth factors, but stress and cytokines also play a predominant role in the activation of 
p38, ERK5 and JNK pathways. 
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The MAP kinase cascades are normally activated by RTKs or GPCRs, both of 
which share the activation of the substrate Ras.  In cancer, RTKs (Schlessinger, 2002), 
GPCRs and Ras (Jacobsen, 2002) have been found to be highly deregulated. Under 
normal, controlled signal transduction, a RTK stimulates Ras through a process that 
includes receptor dimerization, autophosphorylation, followed by Grb2 interaction with 
the receptor and the GTPase son of sevenless (SOS).  Activated SOS then activates Ras. 
GPCR activation of Ras begins with GPCR stimulation, followed by activation of 
adenylate cyclase or PLCβ (Lodish, 2008).  PLCβ then stimulates Ras, which is 
positioned upstream of the ERK1 and 2 cascade protein Raf. 
 
 
Figure 2:  ERK-MAPK Signal Transduction 
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 Following Ras activation, the canonical ERK-MAPK cascade in mammals 
transduces a signal to RAF, MEK1 and 2, ERK1 and 2 and terminates with the 
production of transcription factors Elk1, c-fos, c-Jun, CREB and c-Myc.  These 
transcription factors play roles in proliferation, migration and differentiation.  The p38-
MAPK cascade is stimulated by Ras, transduces the signal at the MAPKKK level using 
MLK3, ASK1 or MEKK4 to MKK3/6, then to p38 and terminates with the production of 
the transcription factors ELK-1, ATF2, CHOP and MSK. 
 
1.3 Ras Mutations 
Ras is the most well studied, commonly mutated gene in cancer.  There are three 
Ras family members, which are Harvey-Ras (H-Ras), Neuroblastoma-Ras (N-Ras), and 
Kirsten-RasA / Kirsten-RasB (K-Ras) (Stitles and Ravichandran, 2009).  Ras mutations 
resulting in the constitutively active form are frequently found in human cancers.  In head 
and neck cancers for example, Ras mutations are found in 50% of thyroid cancer.  In the 
skin and liver, N-Ras is mutated in 14% and 30% of tumors, respectively.  Kidney and 
bladder tumors contain H-Ras mutations in 10% of tumors.  The rate of Ras mutations 
can be as high as 90%, as is the case for K-Ras mutations in pancreatic cancers.  Overall, 
Ras genes are found to be mutated in about 30% of all cancers.  
Ras is located downstream of many different RTKs (EGFR) and GPCRs (GPCR 
Gβγ) that are associated with cancer (Gutkind, 1998).  Ras activates many signal 
transduction pathways that are associated with cancer development (Stitles and 
Ravichandran, 2009).   This positioning makes Ras a molecular cross road of integrated 
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signals which are transduced from the membrane, through multiple signaling to the 
nucleus (Pecorino, 2006). 
  The Ras protein has intrinsic GTPase activity which hydrolyzes GTP, converting 
the GTP bound form of Ras to the GDP bound form (Karnoub and Weinberg, 2008).  The 
exchange rate between the GTP and GDP is controlled by GTPase activating proteins 
(GAPs) and guanine nucleotide exchange factors (GEFs) (Donovan et al., 2002).  These 
GAPs and GEFs constitute the Ras cycle, which describes the cyclic changes in 
concentrations between the active GTP bound form and inactive GDP bound form.  
  
Figure 3:  The Ras Cycle 
 
Biochemical Journal (1996) Volume 318, 729-747 
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Following receptor activation, the GTP-bound Ras form will increase 2-3 fold and 
remain high for at least 30 minutes (Denhardt, 1996).  A GAP will hydrolyze the GTP 
bound form, resulting in a conformational change and termination of the signal.  Static 
Ras GTPase activity is enhanced by GAPs, but in oncogenic Ras GAP’s efficacy is 
reduced, leading to increased concentrations of GTP-bound Ras.  In the GTP-bound form, 
the Ras kinase cascade interacts with many downstream effector proteins, such as Raf of 
the ERK-MAPK, ASK1 of p38-MAPK PI-3K and Ral-GDS.  
 
Figure 4: Ras Pathway in Cancer 
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As described earlier, these MAPKKKs are responsible for commencing signal 
transduction of their respective cascade to the nucleus, eventually eliciting the 
phosphorylation of specific kinases in their particular cascade.  Phosphorylation of 
MAPK results in the activation of transcription factors, such as Elk-1, SAP-1, c-Myc, 
CREB, c-Jun and ATF-2.   The regulation of the Ras kinase cascade, and activation of 
subsequent transcription factors are regulated mainly by the GEFs and GAPs (Bos, 2007).   
 A mutation in any of the Ras genes that leads to an increased fraction of Ras in 
the GTP-bound form has the potential to cause cancer.  These Ras mutants, which bind 
GTP more than wildtype are known as constitutively active Ras mutants.  Among these, 
K-Ras is the most commonly mutated Ras protein found in human cancers (Karnoub and 
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Weinberg, 2008). These constitutively active mutants have been associated with cancer 
through hyperactivation of the MAP Kinase signaling cascades.   
 
1.4 Cell Surface Receptors 
 Cell-surface receptors such as receptor tyrosine kinases (RTK) and G-protein 
coupled receptors (GPCRs) are responsible for transducing signals from outside the cell 
to the cytoplasm.  RTKs and GPCRs, through the stimulation of Ras, are responsible for 
the regulation of the MAP kinase cascades.  Receptor tyrosine kinase (RTK) regulates 
many aspects of cell activity, such as proliferation, differentiation, survival and 
metabolism.  
  
1.5 Receptor Tyrosine Kinases 
RTKs are activated by ligands, such as epidermal growth factor (EGF), platelet 
derived growth factor (PDGF), fibroblast growth factor (FGF), and nerve growth factor 
(NGF).  RTKs are involved in the first step of moving a growth factor signal from outside 
the cell to inside the nucleus where gene regulation occurs. RTKs are consisted of an 
extracellular binding domain and cytoplasmic domain, and they are connected by 
transmembrane domain.  RTKs are responsible for initiating growth factor stimulated 
signal transduction. The process beings when a growth factor enters the pocket created by 
extracellular domain I and III.  The growth factor causes dimerization, bringing the 
kinase domain of one receptor in close proximity to the kinase domain of the other 
receptor.  The result is autophosphorylation of the activation loops on the cytoplasmic 
domain.  The autophosphorylation reveals the catalytic domain through a conformational 
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change (Percoino, 2006).  Further phosphorylation occurs, creating high-affinity binding 
sites for other proteins which contain Src homology 2 (SH2) domains.  These docking 
sites recruit specific kinases. 
 These phosphorylated tyrosine residues can recognize proteins containing SH2 
domains or SH3 (Src Homology 3 or PTB) domains.  The MAP kinase cascade begins 
with interactions between the SH2 domain of GRB2 and the phosphorylated cytosolic 
domain of EGFR, for example. GRB2 contains SH2 and SH3 domains; the receptor is 
recognized through the SH2 domain, and two SH3 domains are used to interact with son 
of sevenless (SOS). Following GRB2 interaction with SOS, SOS activates Ras, which 
leads to Ras eliciting many different signaling cascades (Percoino, 2006). 
 
1.6 G-protein Coupled Receptors 
G-protein coupled receptors (GPCRs) are also responsible for the initiation of the 
MAP kinase cascade.  All GPCRs share common functional / structural designs.  They all 
share a 7-transmenbrane receptor, a heterotrimeric G-protein consisting of three subunits 
(α, γ, and β), a membrane-bound effector protein, and a regulatory loop as a basic 
machinery.  The combination of different types of heterotrimeric G protein Gαβγ together 
with GPCRs and its ligand defines the quality and quantity of downstream signaling.   
During the inactive period, Gα and Gβγ are associated with the membrane as a one protein 
complex.  During the activated period, Gα dissociates from Gβγ and cycles from the 
complex to the effector protein, such as Ras, which is an effector protein to the MAP 
kinase pathway.  Once free from the trimeric protein, GTP-bound Gα is free to activate 
the MAP kinase cascade.  The differences among GPCRs arise from the stimulating 
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ligands and the combination of G-proteins attaching to the GPCRs (Gutkind, 1998).  To 
date, 21 different Gα subunits, 6 Gβ subunits and 12 Gγ subunits are known.   
 LPA and thrombin were the first agonists discovered that stimulate quiescent 
mammalian cells by accumulating Ras-GTP.   Other agonists also exist, which cause the 
GPCR to release the subunits Gi/o, Gq, Gs, and G12. Each subunit induces a specific 
signaling cascade.  The signaling cascade induced defines each specific subclasses. For 
example, Gs-coupled receptors lead to increased levels of cyclic adenosine 
monophosphate (cAMP) via the adenylate cyclase pathway, Gi leads to decreased cAMP 
via the inhibition of adenylate cyclase, Gq leads to the upregulation of intracellular 
calcium concentration by activating the PLC pathway, and G12 interacts with Cl channels.  
In addition, other functions have been described for these G protein Subunits (Zheng, 
2004).  
  
1.7 PI-3K/AKT Pathway 
Once Ras is activated, it can stimulate two pathways; The PI-3K pathway or the 
canonical MAP kinase pathway.  The PI3K pathway is stimulated by some G-protein 
coupled receptors.  The GPCR activates phosphoinositide-3 kinase (PI-3K), and then the 
β isoform of phospholipase C (PLCβ) is commonly activated.  PLCβ is an enzyme which 
cleaves phosphatidylinositol 4,5-bisphosphate (PIP-2), and eventually leads to activation 
of protein kinase C (PKC).  PKC alters gene expression profiles involved in cell division 
and apoptosis.  PI3-K also activates AKT.  AKT phosphorylates BAD followed by the 
interaction with 14-3-3.  BAD releases the anti-apoptotic protein Bcl-xL.  Breaking down 
the BAD Bcl-xL heterodimer increases the affinity of BAD for BAX, a pro-apoptotic 
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protein.  The result is inhibition of the apoptotic pathway, and cell survival. (Lodish, 
2008). 
 
1.8 Scaffolding Proteins 
Each of the MAP Kinase cascades are typically diagrammed by an ordered, one-
way model of protein cascades (Kolch, 2005). A better representation would show the 
kinases as essential elements of each cascade.  Each kinase is needed for the cascade to 
continue signal transduction, but many other key interactions are also occurring to allow 
continuation of the cascade.  The other interactions occur between binding partners and 
the kinases.  The existence of binding partners or more specifically scaffolding proteins 
has been proposed as a mechanism to explain the complexity of shared substrates in the 
MAP Kinase signaling pathways.  These scaffolding complexes function to localize 
binding partners to specific regions of the cell.  By localizing kinases with their proper 
substrate, the binding protein ensures continuation of the kinase cascade, despite low 
concentrations of the substrate. These scaffolding proteins play a regulatory role involved 
in colocalization, the prevention of crosstalk, and aid in maintaining specificity 
(Whitmarsh, 1998).  The colocalization function is important because the scaffolding 
proteins bring successive members of the MAP Kinase cascade together, facilitating 
phosphorylation.  The second function is important to prevent interactions between 
functionally unrelated kinases.  In this respect, the binding proteins serve as an insulator 
between different pathways (Whitmarsh, 1998). 
Many examples of this type of regulation have been explained.  Some of the more 
well-known examples of scaffolding proteins include kinase suppressor of Ras 1 (KSR1), 
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MEK partner-1 (MP1), and β-arrestins (Kolch, 2005).  Scaffolding proteins have been 
isolated from each of the four MAPK signaling cascades.  MP1 was found to be a 
scaffolding protein between MEK 1 and ERK 1, of the ERK-MAPK cascade.  JIP-1 (JNK 
interacting protein-1 (Dickens, 1997)) was found to be a scaffolding protein between 
JNK and MKK7, of the JNK-MAPK cascade.  Representative examples are indicated 
below as Table 1. 
 
Table 1:  Known Scaffolding Proteins  
Scaffolding Proteins β-Arrestins CNK KSR MEKK1 MP1 
G Protein  Ras    
MAPKKK Raf Raf1 Raf1 Raf1 Raf1 
MAPKK MEK1  MEK1 MEK1 MEK1 
MAPK ERK2 ERK ERK1/2 ERK2 ERK1 
 
Scaffolding Proteins SUR-8 β-Arrestins JIP-1 JIP-2 JIP-4 
G Protein Ras   Ras-GRF  
MAPKKK Raf1 ASK1   MEKK3 
MAPKK  MKK4 MKK7 MKK7 MKK7 
MAPK  JNK3 JNK JNK/p38 JNK/p38 
 
1.9   p38 γ (ERK6) 
Previous work done by our group examined the MAP kinase ERK6 (p38γ).  Rit, a 
member of the Ras family GTPases, was found to be a specific activator of ERK6.  Rit 
did not activate other MAPKs in NIH3T3 cell systems.  Those results led to the 
hypothesis that there may be an active binding partner of ERK6, working as a scaffolding 
protein similar to MP1, JIP-1, and KSR in their respective MAP Kinase signaling 
cascades.  A yeast two-hybrid study suggested a novel interaction between ERK6 (p38γ) 
and the polarity complex protein Scribble.   
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1.10 Polarity 
 Cell polarity is important to processes such as cell division, transportation of 
molecules across epithelial membranes, and cell crawling among others (Dow et al., 
2008).  The function of cell polarity is to provide the cell with directionality through a 
basal and apical region.  Polarity makes the processes of differentiation, migration and 
proliferation possible.  Within the cell, organelles are arranged in an asymmetrical pattern.  
The asymmetrical arrangement pattern, or polarity, is determined by the interaction of 
three complexes of proteins. 
 
1.11 Polarity Complex Proteins 
Three polarity molecules work to maintain the apicobasal orientation in the cell.  
They are the Par, Crumbs (Crb) and Scribble complexes (Humbert, 2003).  The three 
complexes are localized in specific regions throughout mammalian cells.  
The Crumbs (Crb) complex is localized in the subapical region.  The Crumbs 
molecule is the only molecule of this complex embedded in the plasma membrane.  The 
other two molecules formed complex with Crb are Pals and Patj, which remain in the 
cytoplasm.  The Crumbs complex corresponds with a basolateral complex, 
Scribble/Dlg/Lgl, located below the adherns junction. The function of the Crumb 
complex is to inhibit the Scribble/Dlg/Lgl complex. 
The Par complex is responsible for activating the translation of the Cyclin E and 
DIAP1 proteins by hyperphosporylating Lgl, thus releasing it from the ternary complex.  
This hyperphosphorylation is done by aPKC in the Par3 and Par6 complex. 
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Three molecules are maintained within the Scribble complex.  They are the 
Scribble, Dlg, and Lgl molecules.  The Scribble and Dlg molecules are connected by the 
GUK-holder (GUKH).  The third molecule in the complex is Lgl.  Lgl moves between 
the Scribble/Dlg complex according to the phosphorylation status of Lgl.  When all three 
molecules are present in a ternary complex, translational inhibition of Cyclin E and 
DIAP1 occurs. Both Cyclin E and DIAP 1 are important for continuation of the cell cycle.  
When the proteins are absent, the cell is prevented from entering into the next stage.  
Hyperphosporylation of Lgl releases Lgl from the Scrib/Dlg/Lgl complex.  Lgl locates to 
the nucleus and translational inhibition is lifted. 
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1.12 Scribble Localization and Structure 
Scribble, Dlg and Lgl are most effective when they are localized in the basolateral 
region of the cell.  Their localization is dependent on the LAP family of molecules which 
they belong.  The LAP (Leucine, PDZ) proteins are identifiable by leucine rich repeats 
(LRR), and PDZ domains (Dow et al., 2008).  Specifically, the Scribble protein is a 
195kDa protein that contains 16 LRRs and 4 PDZ domains.  The LRR importance in 
localization is demonstrated by the repeat being conserved among many species.   
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1.13 Polarity Complex Proteins Clinical Effects 
Scribble also functions to regulate the lateral growth of cells.  When Scribble is 
involved in cancer development, it has been shown to disrupt normal apical and 
basolateral growth, along with the regulation of cell death pathways in vivo and in vitro 
(Zhan, 2008).  Carcinomas provide a good model system for unregulated lateral growth. 
Carcinoma progression is marked by disruptions in the architecture of the cell and tissue.    
In 2008, a new model was proposed which described the steps leading up to the initiation 
of the carcinoma state.  The carcinoma state is the result of mutations in a morphogenesis 
cycle.  Normal cells exist in a morphogenesis cycle.  In this cycle, normal epithelial cell 
numbers increase and decrease in accordance with events such as pregnancy and wound 
repair.  This cycle of cell proliferation and morphogenesis repeats many times during the 
life of the cell (Zhan, 2008).  Problems that lead to the development of carcinomas occur 
when polarity complex molecules, which regulate the morphogenesis cycle, loose 
regulation.  The immediate result is dysplastic growth, where the lateral borders of cells 
grow within the normal restraints.  At this point, cell proliferation rates remain normal.  
Eventually, the altered PCP continues to disrupt signaling pathways which leads to 
increased cell numbers and a hyperplasia state.  The neoplastic growth that defines 
carcinomas can only occur with the combined effects of unregulated cell proliferation and 
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1.14 Epithelial-Mesenchymal Transition  
Epithelial-Mesenchymal Transition (EMT) is normally a tightly regulated set of 
events, where cell-cell and cell-extracellular matrix interactions are altered to allow 
epithelial cells to be released from the surrounding tissue (Radisky, 2005). EMT is 
essential for the development of normal cells, but when EMT becomes unregulated, 
cancer can be the result.  
 The process of EMT begins with cells organized in epithelial sheets.  The 
epithelial structure is maintained by tight junctions, adherens junctions, gap junctions and 
by cell-ECM interactions directed by proteins such as intergrins. As epithelial cells loose 
their structure they develop into mesenchymal cells.  Mesenchymal cells have reduced 
cell-cell contacts and lack the cytoskeletal structure found in epithelial sheets (Radisky, 
2005).  The lack of a cytoskeletal structure results in reduced polarity.  Specifically, 
during EMT there is a loss of E-cadherin expression and a upregulation of N-cadherin, 
vimentin and Matrix metalloproteases (MMPs) expression.  The lack of a cytoskeletal 
structure allows mesenchymal cells to become highly motile (Huber, 2005), and serve as 
a source of growth factors such as epidermal growth factor (EGF) , PDGF, and NGF 
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1.15 Cell Adhesion 
  Importantly, Mesenchymal cells show a reduction in E-cadherin levels along with 
an increase of N-cadherin (Lee, 2006).  Cadherins are responsible for creating adheren 
junctions, which create epithelial cell polarity (Yeaman, 1999) by restricting organelles to 
particular regions of the cell. E-cadherins have been found to require the polarity 
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Materials and Methods 
 
2.1 Cell Cultures 
 
293 T cell lines were cultured in Dulbecco’s Modified Eagle Medium (D-MEM) 
(4500 mg/L D-Glucose, L-Glutamine and 110 mg/L sodium pyruvate) (MediaTech, 
Manassas, VA) supplemented with 10% serum supreme (SS) (Lonza, Walkersville, MD.) 
and 1 mL penicillin/streptomycin (10,000 u/mL penicillin,  10,000 µg/mL streptomycin 
sulfate in 0.85% saline).  The cells were incubated in a humidified condition at 37ºC with 
10% CO2. 
 
2.2 Polymerase Chain Reaction 
Reagents were thawed and then reactions occurred in 50μL volumes in 200 μL 
tubes.  Each tube contained 40 μM dNTPs mix, 5 X Green GoTaq Flexi Buffer (Promega, 
Madison, WI), 10 μM Primers,  1 ng/ μL template DNA, 0.25 μL Platinum Taq DNA 
Polymerase (Promega, Madison, WI) and dH2O was added to produce a total volume of 
50 μL.  The tubes were run on GeneAmp PCR System 9700 with varying conditions 
according to the length of the sequence to be cloned. 
Table 2:  Primers used to subclone Scribble Segments 
Scribble Segments Base Pairs Sense Anti-sense 
A 902 ScBam1 ScNot1 
B 1022 ScBam3 ScNot2 
C 1408 ScBam4 ScNot3 
D 1402 ScBam5 ScNot4 
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Table 3A: Primers used to clone Scribble 
Scribble A  
Sense ATAGGATCCAGCGACAACGAGTCCAGGGG 
Anti-sense ATAGCGGCCGCCGCCACGTCCAGCACGTGCAG 
Scribble B  
Sense ATAGGATCCGGGAACCGCCTGCAGAGTCTG 
Anti-sense ATAGCGGCCGCTCCCCTTGACAGAGGGCGCCGA 
Scribble C  
Sense ATAGGATCCGTTTCGTTTGACCAGGCCAAT 
Anti-sense ATAGCGGCCGCCAGCTGCACCGCCTCGCCGTG 
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Table 3:  Primers used to Clone ERK2 and ERK6 
ERK2ΔC  
Sense ATAGGATCCATGGCGGCGGCGGCG  
Anti-sense ATAGCGGCCGCCTCTTCAAAAATTAGTTCTTTTAG 
ERK6ΔC  
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2.3 Restriction Endonuclease Digestion 
In order for the scribble fragments to be inserted into the plasmids, restriction 
endonuclease digestion was performed.  The plasmid used was pEF6/V5-His Vector was 
digested with BamH1 and Not1.  0.5 μL of NotI and 1.0 μL of BamHI.  B buffer at a 
concentration of 10X and a volume of 2 μL was used.  Nuclease-free water was added to 
get a final volume of 20 μL.  The solution was place in the 37ºC air incubator for 1 hour.  
All three vectors pEF6/V5-His A, pEF6/V5-His B, pEF6/V5-His C were digested using 
the same procedure. 
 
2.4 DNA Ligation 
Using a microcentrifuge tube the following were added.  The digest plasmid and 
the digested insert were added at a 1 to 4 ratio of plasmids to insert. 5X Ligation buffer, 
T4 DNA ligase were added.  The final volume was increased to 20 μL through the 
addition of RNase free water.  The solution was incubated overnight at 16ºC in the 
Microcooler II. 
 
2.5 Agarose Gel Electrophoresis 
A 1% agarose gel was prepared using 0.75 mg of Agarose in 75 mL of 1 X TAE 
Buffer.  The products were mixed with 6X DNA running buffer and run side by side and 
run with hyperladder II on the gel for about 20 minutes, or long enough to allow for 
adequate separation. 
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The contents were run on the gel and then the digested products were purified 
using the QIAEX II Agarose Gel extraction kit.  The manufacture’s protocol was 
followed.  It began with the excision of the band of the target length.  A sharp, clean 
scalpel was used.  The excised gel containing the DNA fragment was place in a 
eppendorf tube and then 300 μL of Buffer PE was added, along with 5 μL of QX II.  The 
solution was incubated at 50ºC until the gel has completely dissolved. Every 2 minutes 
the solution was vortexed to redistribute the QXII beads to bind the DNA and aid in 
dissolving the gel.  Once completely dissolved, the tube was centrifuged for 30 seconds 
and the supernatant was removed.  The pellet was washed with 500 μL of Buffer QX1, 
vortexed and then the process was repeated twice using Buffer PE.  The pellet was 
allowed to air-dry for 10-15 minutes or until it becomes white.  To elute the DNA from 
the beads, 20 μL of nuclease-free water was added.  The sample was vortexed again and 
then centrifuged at max speed.  The supernatant, now containing the DNA, was removed 
and placed in a clean tube. 
 
2.6 Spectrophotometric Calculation of Nucleic Acid Concentration 
Estimation of the nucleic acid concentration was performed in DU 640 
Spectrophotometer.  The spectrophotometer was blanked using nuclease free water.  The 
absorbance at 260 and 280 nm were read, and then the RNA concentration was measured. 
 
2.7 E. Coli Transformation 
Cells were removed from the -80º C and thawed on ice.  5 μg of the target 
sequence were added to the tubes containing the E. coli cells.  The E.coli cells were 
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alpha-select chemically competent cells (Bioline, Randolph, MA).  The solution was 
mixed using a pipet tip for a few seconds. The plasmid inserts were allowed to mix with 
the cells on ice for 5 minutes.  The cells were removed from the ice and put in the 42ºC 
water bath for 30 seconds. The cells are put back on ice for 3 minutes to retain the 
plasmids.  500 μL of SOC medium (2% tryptone, 0.5% yeast extract, 0.4% glucose, 10 
mM NaCl, 2.5 mM KCl, 10 mM MgCl2 and 10mM MgSO4) was added to the tube.  The 
cells were placed in a 37°C incubator and shaken for 60 minutes at 200 rpm.  20 μL of 
the cells were then plated on LB agar plates containing 50 μg/mL ampicillin and 
incubated overnight at 37°C.  
 
2.8 Small Scale DNA Preparation 
Miniprep DNA was purified using the Wizard Plus SV Minipreps DNA 
Purification System (Promega, Madison, WI).  Non-star E.coli colonies were selected 
from the LB agar plates.  The colonies were expanded in 3mL of liquid culture.  1.5 mL 
of the liquid culture was pelleted by centrifugation at max speed for 5 minutes.  The 
supernatant was removed, and the pellet was resuspended in 250 μL of Cell Resuspension 
Solution.  The pellet was resuspended by pipeting.  The solution was incubated at room 
temperature for 5 minutes.  250 μL of Cell lysis solution was added to each sample.  Each 
sample was inverted 4 times and then incubated at room temperature for 5 minutes.         
10 μL of Alkaline Protease Solution was added to each sample.  The samples were 
inverted 4 times and then incubated at room temperature for 5 minutes.  Next, 350 μL of 
Neutralization Solution was added to the solution.  The solution was inverted 4 times and 
then centrifuged at 13,300 rpm for 10 minutes.  The supernatant was carefully removed, 
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and added to the spin column.   The spin column was spun down at 13,300 rpm for 1 
minute.  The flow through was discarded.  750 µL of Wash Solution with ethanol 
(Promega, Madison, WI) was added to the spin column and once again the column was 
spun down at 13,300 rpm for 1 minute.  This step was repeated again using 250 µL of 
Wash Solution with ethanol added (Promega, Madison, WI), and the solution was spun 
down for 2 minutes.  Following the spin down, the column was transferred to a sterile 
1.5mL microcentrifuge tube and 100 µL of heated 90°C nuclease free water was added.  
The DNA was eluted by spinning down at top speed for 1 minute.  The DNA solution 
was stored at -20°C. 
 
2.9 Cell Transfection   
 6-well cell plates were coated with PDL-PBS for 30 minutes.  PDL-PBS was 
removed by a wash with PBS.  The layer of PDL-PBS aided the attachment of 293T cells.  
Each well was plated with 293T cells and the cells were allowed to grow to 60% cell 
confluency.  In a sterile 1.5mL microcentrifuge tube 1 µg of DNA was added and then 
100 µL of serum-free media was mixed with the DNA by pipeting.  To the tube 1µL of 
Turbofect was added.  The lipofectant was mixed by pipeting.  The solution was 
incubated at room temperature for 15 minutes.  During the incubation period, the serum 
in the 6-well plate was removed.  The wells were washed with warm PBS and then the 
media was replaced with fresh serum containing D-MEM.  Following the 15 minute 
period the transfection mix was added to the wells.  One well contained alpha-actinin at 1 
µg concentration to serve as a positive control.  The 6-well plate was rocked gently to 
distribute the DNA to all parts of the plate. 
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2.10 Cell Lysis 
 Cells were cultured for 24 hours in an incubator at 37°C, with 90% air and 10% 
CO2.  Cells were removed from the incubator and immediately placed on ice.  Media was 
aspirated and washed twice with cold non-sterile PBS.  Following aspiration of PBS,   
200 μL of cell lysis solution was added.  The cell lysis solution consisted of a premixed 
MAPK lysis buffer of 10 mL 1 M HEPES pH 7.5, 10 mL 0.5 M EGTA pH 8.0, 4.32 g β-
glycerolphosphate, 5 mL 1 M NP-40 lysis buffer, and 625 μL 2 M MgCl2 per 500 mL 
stored at 4°C.  To each 50 mL of the MAP Kinase lysis buffer was added 50 μL 1 M 
DTT, 500 μL 0.1 M PMSF, 50 μL 10 mg/mL aprotinin, 50 μL 10 mg/mL leupeptin, and 
100 μL 1 M orthovanadate (184 mg/mL).  The cell lysis solution remained on the cells 
for 20 minutes, with rocking every 5 minutes.  Cells were scraped from the wells using 1 
mL pipet tips and then transferred into sterile 1.5mL microcentrifuge tubes already on ice.  
The samples were centrifuged at 16,000 x g for 15 minutes at 4°C.  The supernatant was 
then removed and stored at -20°C. 
 
2.11 Western Blot 
 Proteins were resolved on a 10% denaturing polyacrylamide gel containing 0.1% 
SDS.  Proteins were separated for 1 hour 10 minutes at 120 V in 1 X SDS-PAGE running 
buffer (20 mM Tris-Cl (pH 7.9), 100 mM NaCl, 70 mM EDTA, 2% (w/v) SDS).  The 
proteins were transferred to a PVDF membrane (Immobilon-P; Millipore Corp., Bedford, 
MA) for 2 h at 100 V on ice in 1 X transfer buffer (20 mM Tris-Cl (pH 7.9), 100 mM 
NaCl, 70 mM EDTA, 20% MeOH).  The membrane was block with 5% non-fat dried 
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milk in 0.05% Tween-TBS (T-TBS) and rocked for 1 h on a shaker at room temperature.  
The membrane was washed 3 times for 5 minutes per session.  The membrane was then 
incubated in 27E8 antibody diluted 1:1000 (1 μg/mL) in blocking buffer.  The membrane 
was rocked on a shaker at 4°C overnight.  Following three five minute washes in TTBS 
the secondary antibody was applied.  The antibody was diluted 1:5000 (1 μg/mL) in 
blocking buffer on the shaker for 1 h at room temperature.  The interaction between the 
antibodies was detected using Western Lightning Chemiluminescence Reagent Plus 
(PerkinElmer Life Sciences Inc., Boston, MA) 
 
2.12 Immunoprecipitation 
 HA antibodies were added (1μg per 1 mg of protein) to 1 mL of media.  The 
media was then incubated for 48 hours at 4°C and rotated end-over-end.  30 μL of 50% 
Gammabind-G Sepharose in PBS (Pharmacia Biotech AB, Uppsala, Sweden) was added 
to each sample, and the solution was incubated for another 1h at 4°C while being rotated.  
The samples were then centrifuged at 10,000 rpm for 5 minutes at 4°C.  The supernatant 
was removed and 1 mL of PBS was added.  The pellet was resuspended by flicking.  The 
pellet was centrifuged for 1 minute, and then washed again.  A total of three washes were 
performed.  Following 3 X wash, the tube was centrifuged and all remaining supernatant 
was removed with a pipet. The Gammabead-antibody-protein complexes were 
resuspended in 1 X SDS-PAGE loading buffer, heated to 95°C for 10 minutes and then 
run on a polyacrylamide gel. 
 
2.13 MDCK Scribble assay 
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 This assay was performed using two cell lines, MDCK and NIH3T3.  The 
transfection protocol was followed, as described earlier.  Each plate was grown the 60% 
confluency.  4 series of plates were used to examine ERK1, ERK2, and ERK6.  ERK1 
was used as a negative control.  Previous IP results suggested no interaction between 
ERK1 and Scribble.  In each series, 2 plates were serum starved and 2 plates were grown 
in serum containing D-MEM.  The serum and serum free plates were then further divided 
into His-Scribble and ERK1 co-transfected, and  empty vector and either ERK1, 2, or 6 
cotransfected.  This series was performed in MDCK cells with ERK1, ERK2, and ERK6.  
The experiment was duplicated in NIH3T3 cells.  Each series was lysed and then a 
Western blot procedure was performed using a 10% polyacrylamide gel.  The 27E8 
antibody was used to identify and quantify the relative intensity of His-tagged Scribble. 
 
2.14 Focus Formation assay 
 Using NIH3T3 cells, cells were grown to 60% confluency in a 6 cm dish.  We 
used six samples in this study.  Each plate was cotransfected with 2 µg of plasmid DNA 
or empty vector.  The six samples were divided into two groups.  The first group was 
examining ERK6 interactions with Scribble.  One series contained empty vector, the 
other Rit79L, and the last series contained Rit79L and Scribble.  The second group was 
examining Scribble’s interaction with canonical MAPK.  One series was transfected with 
Scribble, the other H-RasV12, and the 3
rd
 series contained H-RasV12 and Scribble.  The 
transfection protocol was followed as described earlier.  48 hours post-transfection, 4 
µg/ml polybrene (Sigma, St. Louis, MI) was added to the supernatant.  The supernatant 
remained on the cells for another 48 hours.  For the focus formation assay, the medium 
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was changed to DMEM, plus supplemental 5% calf serum and 2 mM 1-glutamine.  Fresh 
medium was replaced every 3-4 days for 2-3 weeks, until primary foci appear.  The foci 
were stained with crystal violet and counted. 
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Results 
 
3.1 Yeast Two-Hybrid Assay 
We performed a Yeast Two-Hybrid Assay using ERK6 as bait.  We performed 
this screening three times using a human brain cDNA library as a pool of binding targets. 
As expected, the known upstream regulatory molecule MEK3 was identified as an 
interaction partner with ERK6.  MEK3 was identified in all 3 screening trials.  Besides 
this, we found a previously unknown ERK6 binding partner called Scribble.  Worked 
showed that the binding region of Scribble was contained by the amino acid sequence 
AA580-870.  We decide to obtain a full length Scribble plasmid from the Kazusa DNA 
institute through their HUGE (HUman larGE protein database) project (RIKEN, Kazusa, 
Japan).   
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  41 
Figure. 1 shows Scribble binds to ERK6 with this Match Maker yeast two-hybrid 
system.  ERK5 is displayed as a negative control.  The colonies appearing on the top line 
of the figure were streaked on a plate containing all required nutrients for the growth of 
the yeasts and the negative clone. Growth can occur on this plate without interaction with 
the binding target. The bottom figure shows a yeast two-hybrid assay performed on an 
agar plate with minimal nutrients.  For a colony to grow on this plate, the bait must 
interact with a binding partner whose interaction activates a nutrition compensation 
system in the plasmid sequence. Each constructs are expected to grow if they can 
compensate these minimum requirement nutrition by innate plasmid system indicated by 
one letter abbreviation. LT= Leucine/Tryptophan AHLT=Adenine/Histidine/ 
Leucine/Tryptophan 
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3.2 Scribble Binding with other Kinases 
As described above, Scribble was found to be a binding partner for p38 MAP 
kinase ERK6.  However, it is already known that several other MAP kinases also have 
their own specific partner which functions as a regulatory binding partner, such as MP-1, 
or KSR.  To further investigate the possibility of Scribble binding with other MAP 
Kinases besides ERK6, we prepared several HA-tagged MAP Kinases and performed 
immunoprecipitation assays (IP) using these representative MAP Kinases and Scribble.  
The purpose of this IP was two-fold.  First, we wanted to determine if Scribble bound 
other Kinases, and secondly we wanted to exclude interactions with other kinases which 
may make our annotation difficult if there are additional binding kinases.  
As described in the materials and methods section, a 6-histidine tagged full length 
Scribble was contransfected with each of the HA-tagged MAP kinases.  Fig. 6 shows the 
result of this IP assay.  Surprisingly, this polarity defining molecule Scribble, which was 
originally found to bind with ERK6, was found to also bind with the MAP kinase ERK2.  
Using 293T cell lines as a plasmid expressing eukaryotic cell system, cotransfection was 
performed with the lipofectamine PLUS reagent.  Western blot results developed 
targeting His-tagged Scribble preceded by an IP with anti-HA antibody clearly displayed 
the binding of these two MAP kinases with Scribble.  Other HA-tagged MAP kinases, 
such as ERK1, JNK, p38α, p38β, and ERK5 were not co-precipitated, suggesting they 
are not ERK6 binding partners.  Of note, we could not find any association between 
ERK1 and Scribble.  The result is somewhat surprising, given ERK1 shares 88% 
sequence homology to ERK2 MAP kinase.  Nevertheless, this result was reconfirmed by 
additional immunoprecipitations. 













































Figure 7:  Scribble Binding with MAP Kinases 
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Figure 7:  Scribble Binding with MAP Kinases 
The immunoprecipitation assay was performed by cotransfecting the indicated 
HA-tagged kinases with Scribble into 293T cell lines.  Top panel: Total cell extract 
(TCE) of each transfectant was loaded and western blot was performed with an anti-
HA antibody.  Bottom panel: 6-Histidine tagged ERK6 was contransfected in 293T 
cell lines with several other HA-tagged kinases. IP was then performed with anti-HA 
antibody.  Next, the kinases were eluted, and a western blot was performed and 
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3.3 Defining Binding Domain Between Scribble and Two Kinases 
In the previous immunoprecipitation experiment, it was determined that Scribble 
can bind to two different kinases, ERK2 and ERK6. Next, we would like to know what 
part of Scribble is interacting with the kinases. A DNA domain search was performed 
using the web based scansite program (http://scansite.mit.edu). The program informed us 
that Scribble contains two major motifs, known as Leucine Rich Repeat (LRR) and PDZ 
(PSD95, Dlg-1, ZO-1) domain.  The domains encompassed the sequence of amino acids 
1 to 314 (LRR), and 670 to 1126 (PDZ domain).  To further define the binding 
mechanism between Scribble and the MAP Kinases, we constructed AU1 tagged 
eukaryotic expression vectors containing 4 regions, including the LRR and PDZ domain 
we found particularly interesting. The procedure was described in the materials and 
method section.  As diagrammed in figure 3, four plasmids were constructed following 
the indicated amino acid sequence. These plasmids were named Scribble A, B, C and D. 
Each plasmid independently expressed the AU1 tag and contained the amino acid 
sequence 1-314, 315-669, 670-1126, 1127-1551, respectively.   














Figure 8:  Scribble Expression Vectors  
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 Figure 8:  Scribble Expression Vectors  
Eukaryotic expression plasmids were designed following the predicted domains 
indicated by a web based scanning program.  The top image is a simplified motif of 
Scribble. The full length of Scribble is 1551 amino acids.  The whole sequence was 
subdivided into four regions as described in materials and methods.  Each construct was 
tagged with the AU1 at the N-terminus.  
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3.4 Immunoprecipitation Assay with Subdivided Scribble Constructs 
To further clarify the binding mechanisms between Scribble, ERK2 and ERK6, we 
wanted to find the precise binding domain of Scribble which is interacting with the 
kinases. 293T cells were used for the cotransfection of these Scribble constructs with 
these kinase plasmids. We performed immunoprecipitation assays using this 
contransfected cell line.  The cells were lysed, and anti-HA antibodies were added to each 
lysate.  Gamma-bind G was added to each lysate, and used to pull down these added 
antibodies.  After an additional incubation period, the tubes were washed and a western 
blot was performed. The membrane was developed with an anti-AU1 antibody.  The top 
panel shows the immunoprecipitation results.  This immunoprecipitation clearly exhibited 
the binding of MAP kinases and Scribble.  This western blot suggests Scribble interacts 
with the kinases through Scribble’s LRR and PDZ domain.  In this experiment, full 
length Scribble was also added as a positive control, along with HA-tagged EGFP 
expression plasmid, which served as a negative control.  The middle panel indicates the 
expression status of the HA tagged kinases.  The bottom panel shows the expression 
status of contransfected AU1 tagged Scribble constructs.  The western blot results 
depicted by the middle and bottom panels were prepared by applying total cell extracts 
(TCE) of each lysate, which were aliquotted in advance for this immunoprecipitation 
assay.  As expected, these two kinases bound Scribble, but surprisingly they were found 
to be binding with Scribble by the use of the same domains.   
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Figure 9: Immunoprecipitation Assay to Find Binding Domain of Scribble and Two 
Kinases. 
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Figure 9: Immunoprecipitation Assay to Find Binding Domain of Scribble and Two 
Kinases. 
Top panel: Western blot membrane developed by anti-AU1 antibody. Cell 
lysates were immunoprecipitated by adding anti-HA antibodies and gamma-bind G beads. 
The figure indicates only Scribble plasmids-A, -C, and full length proteins are 
immunoprecipitated with MAP kinases ERK6 and ERK2.  Middle panel: Western blot 
membrane was developed by anti-HA antibody to show the original expression level of 
the cotransfected HA-tagged MAP kinase plasmid constructs. TCE stands for total cell 
extract of each cell lysate.  Bottom panel: Western blot membrane was developed by 
anti-AU1 antibody to show the original expression level of cotransfected AU1 tagged 
Scribble plasmid constructs. TCE stands for total cell extract of each cell lysate. 
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3.5 Full length Scribble and MAPK binding Mechanisms  
After Scribble was found to be binding with these two kinases through the LRR and 
PDZ domain, we tried to clarify the mechanisms of binding between Scribble and MAP 
kinases.  We performed a domain search using the web based scansite program 
(http://scansite.mit.edu) and found each MAP kinase had a different class of PDZ binding 
motifs at the carboxy-terminus.  This region consisted of 3 amino acids.  To confirm if 
these homology predictions are truly functional, we constructed eukaryotic expression 
plasmids coding for a five amino acids deleted portion at the C-terminus of each kinase.  
A  PCR based subcloning technique was applied for this construction as we described in 
materials and methods. 
C-terminus deleted MAP Kinase encoding plasmids were contransfected with full 
length of Scribble plasmids.  After confirming these deletion mutants, plasmids were 
successfully expressed in 293T cells, an immunoprecipitation assay was performed using 
these lysates.  Anti-HA antibody was used to pull down HA-tagged kinases, including the 
deletion mutants.  By adding gamma-bind G beads, we pulled down anti-HA antibodies 
and performed western blot analysis on the membrane.  The results confirmed that the 
minimum C-terminal deletion of the predicted amino acid sequence from each kinase 
completely abrogated the kinases binding to full length Scribble.   
It was noticed that the expression level of the ERK2 deletion mutant was 
dramatically downregulated in this IP.   It is possible that the C-terminus is involved with 
the stable folding of ERK2 MAP kinase.  The wildtype C-terminus may prevent 
degradation, which may induce the ubiquitination process or another unknown 
mechanism.  However, this downregulation found in the ERK2 deletion mutant was not 
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observed in the expression of ERK6 deletion mutants (bottom panel).  After repeating 
this assay, it was noticed that relative detection volume of ERK2 was far smaller than 
ERK6.  We initially obtained only ERK6, and the well known upstream kinase MEK3, as 
a binding partner for Scribble.  ERK2 was retrospectively added to the list of binding 
partner after IP results suggested it may interact with Scribble. The original purpose of 
the IP was to exclude the possibility that other kinases do not bind with Scribble.    
 


































Figure 10. Mutated MAP Kinases and Scribble Interactions 
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Figure 10. Mutated MAP Kinases and Scribble Interactions 
An immunoprecipitation assay was performed using C-terminus deletion mutants 
of each kinase.  These plasmids were cotransfected with a full length Scribble expression 
plasmid in 293T cells. Immunoprecipitation assays and western blot analysis with 
indicated antibodies were performed.  Top panel: Expressed kinase proteins were 
immunoprecipitated by adding anti-HA antibody and further collected by adding gamma-
bind G. The western blot membrane was developed with anti-His antibody.  Middle 
panel: Total cell extracts were resolved by western blot analysis and anti-His antibody 
was applied for the development of this membrane. Bottom panel: Same membrane used 
in the middle panel was stripped off and rehybridization was performed with anti-HA 
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3.6 In Vitro Kinase Assay 
The results suggest a defined binding region between Scribble and the two MAP 
kinases ERK2 and ERK6.  These bindings were confirmed repeatedly by 
immunoprecipitation, were Scribble was detected by pulling down MAP kinases, or by 
detecting MAP kinases by pulling down Scribble.  We originally started this assay to find 
a possible binding partner, which may affect ERK6 MAP kinase activity.  To clarify this 
possibility, an in vitro kinase assay was performed by applying serum as an activator of 
ERK2 and ERK6.  MDCK and NIH3T3 cells were used for this assay, as described in 
materials and methods.  As a negative control, ERK1 was used since we had already 
demonstrated that Scribble cannot bind to this ERK2 homologue.  The top and bottom 
panel on the left exhibited the fact that cotransfection of Scribble itself did not change the 
phosphorylation status of substrate MBP (Myelin Basic Protein).  Coexpression of ERK1 
was also not affected by the presence of Scribble in this in vitro kinase assay.  As 
expected, in both ERK2 and ERK6 cotransfection experiments with cell lines MDCK and 
NIH3T3, downregulation of the phosphorylation status of MBP was exhibited.  In these 
experiments, different levels of downregulation of MBP phosphorylation status occurred 
in each cell line. In MDCK, a striking downregulation of MBP phosphorylation was 
observed with ERK2 and ERK6 cotransfections, but in NIH3T3, downregulation of MBP 
phosphorylation was apparent, but at most was only 60% downregulated when compared 
to the control. 
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Figure 11: In Vitro Kinase Assay 
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Figure 11: In Vitro Kinase Assay 
In vitro kinase assays were performed with or without coexpressing Scribble to the 
indicated kinases in each cell lines. Top panel: (A) MDCK, Bottom panel: (B) NIH3T3 
cells. (-) and (+) indicate the absence or presence of plasmid DNA or the stimuli by 
serum presentation.  On top of each panel, the phosphorylation status of MBP is indicated 
as a scanned image.  To show Scribble has no kinase activating potential, a serum 
deprived set was also prepared as a control in this assay. 
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 3.7 Biological Effect of Scribble on Oncogenicity 
Previous experiments demonstrated ERK2 and ERK6 are binding with Scribble. 
The in vitro kinase assay was performed to determine the role of coexpressed Scribble, 
either as a kinase inhibitor or activator, in an in vitro system.  It was concluded that this 
association is functioning as an inhibitor of these specific MAP kinase activities.  
However, we wanted to know the biological effect of the interaction of Scribble with 
activated ERK6 and Scribble’s effect on the constitutively activated canonical MAPK 
pathway. 
Therefore, we decided to perform a focus formation assay (FFA) using NIH3T3 
and the calcium transfection method.  This assay will elucidate the role Scribble performs 
when it interacts with the kinases.  One highly probable possibility is that Scribble 
functions to suppress the kinase activity.  Previous work from our laboratory revealed 
that RitQ79L is a constitutive activator of the ERK6 kinase pathway in NIH3T3.   
On average RitQ79L activates ERK6 MAP kinase specifically almost 85%.  
Coexpressing RitQ79L with Scribble will examine Scribble’s role when ERK6 is 
overexpressed.  As a control, the constitutively active mutant RasV12 was used as a 
specific activator for ERK1/2.  Empty vector (negative control), H-RasV12 (ERK2 
kinase pathway specific activator), RitQ79L (ERK6 kinase pathway specific activator), 
plus Scribble were cotransfected. The same set was cotransfected on top (Bottom panel).  
The DNA transfection volume was adjusted between these two sets by using empty 
vector for the primary set (Top panel).  As shown in figure 11, the empty vector 
transfected plate showed no foci.  The RasV12 transfected plate showed numerous 
numbers of Ras characteristic foci.  Cotransfection of Scribble reduced the foci formation 
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when compared to the RasV12 transfected positive control.  To confirm the possible 
positive effect of Scribble on foci formation, we carefully examined the Scribble 
transfected plate.   
The Scribble transfection itself showed no positive effect on the foci formation.  
Transfection of RitQ79L, which is a constitutive activator of the ERK6 kinase pathway, 
exhibited a dramatic increase in foci formation.  Cotransfection of Scribble dramatically 
downregulated the foci formation effect by RitQ79.  Thus, by combining previous in 
vitro kinase assay results, we concluded that Scribble can downregulate oncogenicity, if 
those activities are induced through the activation of ERK2 and ERK6 kinase pathways.  
Interestingly, between these two different kinases, we observed different levels of foci 
formation suppression.  As indicated in figure 11, cotransfection of Scribble 
downregulated the focus formation activity induced by the transfection of RitQ79L 
(specifically activates the ERK6 MAP kinase almost 85%, on average).  Cotransfection 
of Scribble with RasV12, which specifically activates the MAP kinase pathway (ERK1/2), 
suppressed only around 30% compared to the suppression ratio by RitQ79L 
cotransfection.  These assays were repeated three times each, but the level of 
downregulation was almost exactly the same in all cases. 
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Figure 12:  Focus Formation Assay (A)
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Figure 12:  Focus Formation Assay (A) 
Focus formation assay was performed with NIH3T3 cell lines.  The calcium 
transfection method was used for the plasmid DNA transfection, and the plates were 
observed for a period of three weeks following transfection.  Then the plates were 
washed and stained as described in materials and methods.  Experiments were triplicated 
and representative images are displayed above.  Top panel:  After three weeks of 
plasmid DNA transfection, plates were stained. Transfected plasmid DNA is indicated 
above. Image shows focus formation results from the transfection of empty DNA vector, 
H-RasV12, and RitQ79L from left to right.  Bottom panel:  Same set of transfections to 
the top panel, but the Scribble expression vector was also cotransfected.  Transfected 
vectors were, empty DNA vector + Scribble, H-RasV12 + Scribble and RitQ79L + 
Scribble from left to right, respectively.






































Figure 13:  Focus Formation Assay (B)
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Figure 13:  Focus Formation Assay (B) 
Results of focus formation assay (FFA) discussed in the previous chapter was 
converted to this graph.  The transfections for the FFA were performed in triplicate 
format and numbers of foci on all the plates were counted twice per plate.  Numbers were 
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Discussion 
 
4.1 MAP kinases and ERK6 
MAP kinases (MAPKs; mitogen-activated protein kinases, also known as 
extracellular signal-regulated kinases or ERKs) are serine / threonine-specific protein 
kinases, which play important roles in cellular activity, such as proliferation, 
differentiation, cell survival, apoptosis, and development.  It is also well documented that 
MAP kinases play crucial roles in pathological conditions, particularly in cancer where 
MAPK signaling is frequently deregulated.  Among these, the most well studied MAP 
kinases are the kinases of the canonical MAP kinase pathways.  These kinases work as 
transducers of hyper-activated proliferation signals. However, due to the complexity of 
the signaling network and interdependency of each kinase pathway, analysis of perturbed 
signaling is usually very difficult, and to overcome this complexity, advanced molecular / 
genetic analysis methods were invented recently, such as DNA microarray system, 
proteome array analysis and bioinformatics studies.  In our previous research, we focused 
on the signaling of the poorly understood MAP kinase, ERK6 (p38).  Through this study, 
our group was successful in specifically activating the oncogenic signaling pathway using 
Rit (Ras-like protein In Tissues).   
 
4.2 ERK6 and Rit 
Rit was initially reported to be a homologue of the small GTPase Ras. Homology 
searches comparing Rit and Ras support the conclusion. Rit belongs to small GTPase Ras 
family tree, and it is expressed systemically in the human body.  The nearest known 
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homologues are Rin and Ric.  Rin is specifically expressed in neuronal cells.  It was 
intensively studied as an important mediator of signal transduction in neuronal cells, but 
many aspects of this molecule still remain uncharacterized.  When a constitutively 
activated Rit plasmid was transfected in NIH3T3 cells using the calcium transfection 
method, numerous RAF-like foci developed on the plate.  At the time, no representative 
signaling pathway was known, until we successfully nailed down it as ERK6 (p38).   
ERK6 belongs to the family of p38 MAP kinase pathways, and it is comprised of four 
homologues known as p38α, p38β, p38γ (ERK6) and p38.  Among these members, 
ERK6 is least understood.  We started to seek the function and the regulatory system 
related to this MAP kinase.  In our previous report, we showed that Rit specifically 
activates ERK6 but not other MAPKs (ERK1/ERK2), JNKs, p38, p38, p38, or ERK5. 
Furthermore, we found that continuous and specific activation of the ERK6 pathway 
through overexpression of the constitutive active mutant RitQ79L induces oncogenicity, 
as judged by focus formation assay in NIH3T3 cells.  Subsequently, we tried to elucidate 
further functional roles of ERK6 in signal transduction.  
 
4.3 Yeast Two-Hybrid Assay with ERK6 
We hypothesized that there may be an active binding partner(s) that works as a 
scaffolding protein like other scaffolding proteins in the MAP kinase pathways. To 
confirm this idea, we sought binding molecules that possibly controlled the signaling 
through the Rit-MAP kinase pathway.  We performed a yeast two-hybrid screening using 
ERK6 as bait, in an attempt to find an ERK6 binding partner and possible kinase 
regulator.  Through this screening, we found ERK6 interacts with MEK3 and the cell 
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polarity defining molecule known as Scribble.  Scribble is a molecule recently found and 
many different groups are intensively studying its functional role.   
 
4.4 MAP Kinase Scaffolding Proteins  
Many other MAP kinases are known to associate with other molecules that work 
as regulators of the MAP kinase it binds to.  For example, KSR1 is known as Ras kinase 
inhibitory factor and it inhibits the canonical ERK signaling pathway.  Another well 
known scaffolding protein exists in the ERK signaling pathway.  It is named MP1 for 
MEK1-ERK1.  Interestingly, this molecule is specifically directed to ERK1, but not 
ERK2.  Two independent -arrestins are known to be interacting molecules between 
ERKs and RAF in the ERK signaling pathway.  In the JNK pathway, a series of JIPs 
(JIP1-JIP4) have been well studied and have been reported as functional downregulators 
of JNK signaling.  In the p38 MAP kinase pathway, several scaffolding molecules are 
now known, such as JLP for p38, OSM for p38, and JIP2 for p38/p38.  The number 
of known scaffolding proteins is gradually increasing in number. To date, more than 10 
molecules are known.  Among these, only JIP2/3 and -arrestin2 are known to be dual-
specific scaffolding proteins.  JIP2 scaffolds MLK-MKK7-JNK, MLK-MKK3-p38 or 
p38. JIP3 scaffolds MEKK1-MKK4-JNK, MLK-MKK7-JNK or ASK1-MKK4/7-JNK. 
-arrestin2 is scaffolding Raf-1-MEK1-ERK2 or ASK1-MKK4-JNK3.  These are the 
only three dual-specific scaffolding proteins known, and no other scaffolding molecules 
have been discovered for ERK6 (p38).  Importantly, this molecule had dual-specificity 
for the other MAP kinase ERK2.  Also of interest was Scribble, which had a specific 
selectivity that distinguishes between the classical MAP kinases ERK1 and ERK2.  As 
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far as we know, the only other scaffolding molecule that can distinguish between ERK1 
and ERK2 is MP1.  Recently, many new reports are starting to advocate the importance 
of the different roles these two classical MAP kinases perform in the signaling cascade.  
Previously, the ERKs were categorized as MAP kinase ERK1/2.  It was one simple MAP 
kinase group, with no outstanding biological distinction in most scientific descriptions.  
With the research progression due to the application of newly developed technology, 
such as gene knockouts, siRNA and shRNA based gene knockdown, new independent 
biological roles of ERK1 and ERK2 are now gradually being elucidated.   
 
4.5 Scribble as a Multi-Valent Scaffolding Protein 
Scribble performs an important molecular role in the cell.  To date, Scribble is 
known as a molecule that forms a hetero-dimer with Dlg at the basolateral junction. This 
dimer associates with Lgl, forming a ternary complex.  The ternary complex works in 
controlling cell cycle machinery (Humbert, 2003).  Scribble not only works as machinery 
for cell cycle, but Scribble is also known to establish cell polarity, as described in the 
introduction.  Therefore, once the molecule or molecules associated with the Scribble 
scaffolding complex are perturbed, this molecule can play a role in regulating 
oncogenesis.  Taking into account our new findings, this complex molecular pathway 
should be reassessed.  
 
4.6 Scribble and MAP Kinases 
 We found that ERK2 and ERK6 share a binding region in the LRR and PDZ 
domain of Scribble, but the precise regulatory mechanisms of binding between these 
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MAP kinases and Scribble need to be elucidated. Our work examined possible kinase 
binding domains on Scribble.  The test showed interactions with the LRR and PDZ 
domains, but the work is only a preliminary indication of the physical association 
between Scribble and the two kinase molecules.  The next step should include spatio-
temporal kinetics of this association.  Input signal dependent, and time-lapse based direct 
observation of this molecular association will be a good starting point.  One way to do 
this would be to label the kinases with different wave length absorbing fluorescent 
proteins, such as GFP or YFP.  We can then examine the dynamic kinetic change 
resulting from upstream signal input.  As discussed in the results section, we observed a 
difference in the binding affinity between ERK2 and ERK6.  We found that the affinity 
of Scribble to ERK6 is apparently a few times stronger than its affinity to ERK2.  We 
believe this phenomenon maybe explained in the context of signaling modification, 
which varies in a time dependent manner.  Further characterization of these binding 
mechanisms is required 
 
4.7 Possible Role in Interaction Between Scribble and Kinases 
As we discussed above, we still do not know the exact mechanism of the 
interaction between Scribble and the Kinases.  However, ERK1 and ERK2 knockout 
mice may give us a chance to sort out some of these roles.  An ERK2 knockout study 
suggests that an ERK2 knockout mouse is embryonic lethal, since ERK1 is unable to 
compensate for the lack of ERK2 function (Yao, 2003). The ERK1 function can 
adequately be compensated for by ERK2 function in most cells lines, excluding cell lines 
deficient in B-cells (Pages, 1999).  Also, ERK2 activation is a major factor in promoting 
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tumor development (Vantaggiato, 2006) Suppressing ERK2 activation through Scribble 
binding could be a good candidate for a tumor suppressing system.   
The ERK6 knockout phenotype is already known.  Beardmore et al., reported that 
ERK6 knockout mouse can survive under normal conditions without any obvious 
physiological deficits.  However, normal development of ERK6 knockout mice should 
not cause one to undervalue the importance of this molecule.  A possible explanation for 
why the knockout mice do not die may be explained by the redundancy in the p38 
signaling cascade.  The several coexisting homologues that exist in the p38 signaling 
cascades may suggest the opposite, which is the p38 MAP kinase pathway is important 
enough to require coverage by several different homologues.  Actually, it is reported that 
the difference of upstream MEKs, such as MEK3 or MEK6 can induce a different cardiac 
expression phenotype, which is usually simply categorized as ERK6 upstream activator. 
Thus, we presume subtle differences in the selectivity of the ERK6 scaffolding partner 
may cause different outputs which alter the biological phenotype of the cell.  
 In all biological molecular phenomenons, molecular activity is governed by the 
timing and placement of the interacting cells. MAP kinases are usually transported 
between the cytosol and the nucleus at a rate depending on the phosphorylation status of 
the kinase (Marchi, 2008)  However, we still have no clear information explaining how 
these kinases are distributed in the cell when their kinase pathways are not active.  One 
possibility is that when these kinases are in their resting state, they may attach to several 
different molecules, allowing the kinases to “rest”. It is possible that Scribble may 
perform a similar function.  Since kinases spend much time responding to input 
originating from extracellular stimuli, the kinases need to exist in cytosolic region as a 
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pool of ready-to-respond signaling proteins.  Interestingly, unlike the other p38 MAP 
kinases, ERK6 is reported to remain in the cytoplasm even when the nuclear export 
mechanism is inhibited by leptomycin B (Court, 2002). This anomaly may be explained 
by the interaction of ERK6 with Scribble. Remember, Scribble forms a hetero-dimer with 
Dlg and localizes itself in the basolateral region in the cell.  Perhaps ERK6 may also 
interact with the complex.   
The majority of cells in the human body function to maintain homeostatic activity.  
It is possible that these cells are innately programmed to continuously switch the kinases 
between active and inactive status, in order to maintain homeostasis.  We expect that our 
findings will shed new light on the mechanisms connecting events which are presently 
independently described , such as the cell cycle, cell polarity and kinase activity. 
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4.8 Future Directions 
It was found that Scribble was functioning as a scaffolding molecule for the 
kinases ERK6 and ERK2 of the MAP Kinase signaling pathway.  However, we are still 
unsure of the exact interacting domains between these two MAP Kinases and Scribble.  
We know that this interaction can occur between the LRR and PDZ domain of Scribble, 
and possibly the C-terminus of MAP kinases, but this is still a rough map of the 
interaction and needs to be clarified.  As described in the discussion section, the possible 
degradation and modification of the MAP kinase structure due to the loss of C-terminus 
amino acids could result in the loss of kinase binding with Scribble. To elucidate this 
possibility, we are now planning to make N-terminus deletion mutants of the MAP 
kinases. These mutants will be used to perform immunoprecipitation assays.  
Alternatively, we could use a two-hybrid system for the precise detection of interacting 
domain.  In our previous work, the Match Maker 3 system was used, but this system has 
some serious advantages and disadvantages.  The biggest advantage is the availability of 
numerous cDNA libraries which can be used to seek unknown binding partners.  The 
greatest disadvantage of this screening system is the efficiency in screening for the 
binding partner.  The problem is the large number of pseudo positives.  It was a serious 
problem in our screening and the only solution was to spend several weeks to ensure the 
elimination of pseudo positives.  To overcome this problem, we are planning to utilize 
two recently developed hybrid screening systems.  We already checked tone of the 
systems using several different baits and it was proven that this system has far lower 
background noise, or false positives, than previous systems.  We will use the same 
fragments as were used in the immunoprecipitation assay part described above.  The 
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result of this assay should narrow down the possible interacting domains.  In most cases, 
these two-hybrid systems produce results that are more accurate than 
immunoprecipitation assays in terms of the detection of interactions.   This information 
should give us a chance to use these results for the development of inhibitors to these 
Scribble and ERK molecular interactions.  
 Another important study to mention is the binding assay with Scribble and a 
kinase that appears one or two levels upstream, such as Rit, or MEK3 for example.  We 
have performed a very precise immunoprecipitation assays using sequence separated 
expression plasmids of Scribble.  But, if Scribble is in fact a kinase suppressor of the 
ERK2 and/or ERK6 signaling pathways, they may also interact with each other.  As we 
have already found in the two-hybrid study, ERK6 showed physical interaction to MEK3 
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